Current strategy in the treatment of calcium pyrophosphate crystal deposition disease

Abstract

The paper considers currently available drugs used to treat calcium pyrophosphate crystal deposition disease. It discusses the advantages and disadvantages of the most widely used drugs, such as nonsteroidal anti-inflammatory drugs, colchicine, glucocorticoids, traditional immunosuppressants, as well as prospects for the use of biologic agents.

Keywords

• calcium pyrophosphate crystal deposition disease
• colchicine, methotrexate, glucocorticoids